-
-
-
-
-
-
-
Zentalis Pharmaceuticals (ZNTL) PT Lowered to $2 at Leerink Partners
-
-
-
-
-
-
-
Zentalis Pharmaceuticals Reports Full Year 2024 Financial Results and Operational Updates
-
-
-
-
-
-
-
Zentalis Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates
-
-
-
-
-
-
-
Zentalis Pharmaceuticals Appoints Dr. Iris Roth as Chief Operating Officer
-
-
-
-
-
-
-
Zentalis Pharmaceuticals Appoints Dr. Jan Skvarka to its Board of Directors
-
-
-
-
-
-
-
Zentalis Pharmaceuticals Appoints Oncology Clinical Development Veteran Dr. Kimberly Blackwell as Chief Executive Officer
-
-
-
-
-
-
-
Zentalis Pharmaceuticals Reports First Quarter 2021 Financial Results and Operational Update
-
1,231,056 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


